Proto Script Pharmaceutical

(OTC) PSCR

Current Price$0.00

Market Cap$5,700

Since IPO (2016)-100%

5 Year-99%

1 Year-67%

1 Month+0%

Proto Script Pharmaceutical Financials at a Glance

Market Cap

$5,700

Revenue (TTM)

$604.98K

Net Income (TTM)

$8.39M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

28.07 (High)

Dividend

$0.00

Beta (Volatility)

28.07 (High)

Price

$0.00

Volume

1,900

Open

$0.00

Price

$0.00

Volume

1,900

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

28.07 (High)

Price

$0.00

Volume

1,900

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

PSCR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Proto Script Pharmaceutical

Industry

Healthcare Providers and Services

Sector

Health Care

Headquarters

Rancho Cucamonga, CA 91730, US

PSCR Financials

Key Financial Metrics (TTM)

Gross Margin

72%

Operating Margin

-38%

Net Income Margin

-9%

Return on Equity

Return on Capital

93%

Return on Assets

-42%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-0.83%

Stock Overview

Market Cap

$5.70K

Shares Outstanding

56.90M

Volume

1.90K

Avg. Volume

30.159

Financials (TTM)

Gross Profit

$564.47K

Operating Income

$298.08K

EBITDA

$292.96K

Operating Cash Flow

$44.10K

Capital Expenditure

$15.23K

Free Cash Flow

$28.88K

Cash & ST Invst.

$3.51K

Total Debt

$51.29K

Proto Script Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2017YOY CHG

Revenue

$251.97K

+17.8%

Gross Profit

$213.78K

+22.6%

Gross Margin

84.84%

N/A

Market Cap

$5.70K

N/A

Market Cap/Employee

$438.46

N/A

Employees

N/A

Net Income

$283.65K

-190471.1%

EBITDA

$163.56K

-11892.0%

Quarterly Fundamentals

Name

Q3 2017YOY CHG

Net Cash

$372.75K

-387.6%

Accounts Receivable

$166.44K

-32.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$372.75K

+353.3%

Return on Assets

-42.20%

N/A

Return on Invested Capital

93.23%

N/A

Free Cash Flow

$24.90K

+39.6%

Operating Cash Flow

$24.30K

+36.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AMCTAmerican Education Center, Inc.

AMCTAmerican Education Center, Inc.$0.00+0.00%

MHHCMHHC Enterprises Inc.

MHHCMHHC Enterprises Inc.$0.00+0.00%

FIFGFirst Foods Group, Inc.

FIFGFirst Foods Group, Inc.$0.00+0.00%

OLNKOneLink Corporation

OLNKOneLink Corporation$0.00+0.00%

XREGXR Energy, Inc.

XREGXR Energy, Inc.$0.00+0.00%

CESXCES Synergies, Inc.

CESXCES Synergies, Inc.$0.00+0.00%

SYEVSeychelle Environmental Technologies, Inc.

SYEVSeychelle Environmental Technologies, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.36+2.62%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.74-0.02%

PNSkycorp Solar Group

PNSkycorp Solar Group$5.82+1.03%

XNDUXanadu Quantum Technologies

XNDUXanadu Quantum Technologies$14.53-0.60%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.02-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.87+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$51.22+0.02%

Questions About PSCR

What is the current price of Proto Script Pharmaceutical?

Proto Script Pharmaceutical is trading at $0.00 per share.

What is the 52-week range for Proto Script Pharmaceutical?

Over the past 52 weeks, Proto Script Pharmaceutical has traded between $0.00 and $0.00.

How much debt does Proto Script Pharmaceutical have?

Proto Script Pharmaceutical total debt is unavailable.

How much cash does Proto Script Pharmaceutical have on hand?

Proto Script Pharmaceutical does not have cash on hand data available.

What is Proto Script Pharmaceutical’s dividend yield?

Proto Script Pharmaceutical does not currently have a dividend yield.

Proto Script Pharmaceutical

Proto Script Pharmaceutical Financials at a Glance

PSCR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Proto Script Pharmaceutical

PSCR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Proto Script Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PSCR

What is the current price of Proto Script Pharmaceutical?

What is the 52-week range for Proto Script Pharmaceutical?

How much debt does Proto Script Pharmaceutical have?

How much cash does Proto Script Pharmaceutical have on hand?

What is Proto Script Pharmaceutical’s dividend yield?

Premium Investing Services